Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyAmeriHealth precertification policy update | OpenP…
    Ask Trek AI about this page
    CurrentAmeriHealthPolicy N/A

    Precertification Requirements for Elective (Non‑Emergency) Services

    Customize your policy alerts

    Sign up for all AmeriHealth policy alerts

    Know when AmeriHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists services, tests, drugs and devices that require precertification for elective (non-emergency) care and clarifies that precertification does not guarantee coverage; applies to AmeriHealth commercial and Medicare Advantage members as indicated. Some reviews are performed by independent review vendors.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerAmeriHealth
    PolicyPrecertification Requirements for Elective (Non‑Emergency) Services
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2025
    Next Review DateN/A
    Key ActionObtain precertification for listed elective/non-emergency services before scheduling; precertification does not guarantee benefit coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+Service categories listed
    100+Specialty drugs listed
    81400-81408Non-specific CPT codes flagged
    multipleExternal reviewers
    7/1/2025Policy effective

    Precertification-required Services and Test/Agent Lists

    Precertification-required services (partial list)

    Precertification required for the following elective/non-emergency services; listing is a guide and does not by itself establish coverage.

    Precertification is required for the following elective/non-emergency services; a precertification determination does not guarantee coverage — member benefit plan terms and exclusions must be reviewed.

    Inpatient services

    • Acute rehabilitation admissions
    • Elective surgical and nonsurgical inpatient admissions
    • Inpatient hospice admissions
    • Long-term acute care (LTAC) facility admissions
    • Skilled nursing facility admissions

    Cardiology procedures

    • Arterial ultrasound
    • Diagnostic coronary angiography
    • Percutaneous coronary intervention

    Procedures requiring precertification

    • Spine surgeries (various listed)
    • Joint arthroplasties and arthroscopy
    • Obesity surgery
    • Cochlear implant surgery
    • Vertebroplasty/kyphoplasty

    Reconstructive/cosmetic and related surgeries

    • Breast procedures (reconstruction/reduction/augmentation)
    • Facial and skin procedures
    • Gender-affirming interventions
    • Hair transplant
    • Injectable dermal fillers
    • Varicose vein surgery

    Ambulance and day rehab

    • Elective ground, air, and sea ambulance
    • Day rehabilitation programs

    Interventional pain management

    • Epidural injections and nerve blocks
    • Implanted spinal cord stimulators
    • Sacroiliac joint injections
    • Facet injections

    Advanced imaging and radiology

    • CT/CTA
    • MRI/MRA
    • Nuclear cardiology
    • PET
    • Echocardiography (TTE/TEE/Stress)

    Prosthetics, orthoses, DME

    • Custom orthoses and prosthetics
    • Bone growth stimulators
    • CPAP/BiPAP and supplies
    • Power wheelchairs and POVs
    • Insulin pumps
    • Speech-generating devices
    • Pressure-reducing support surfaces

    Other therapies and services

    • Medical foods
    • Hyperbaric oxygen therapy
    • Proton beam therapy

    Behavioral health and substance use

    • Inpatient and intensive levels of mental health care
    • Partial hospitalization (PHP), intensive outpatient (IOP), outpatient substance use programs — note: some mandated services may not require precertification

    Autism services

    • Applied behavioral analysis (precertification review provided by Magellan Healthcare, Inc.)

    Genetic and genomic testing

    • Hereditary cancer and heart disease panels
    • Full gene analysis (e.g., cystic fibrosis)
    • Expanded carrier screens
    • Specialty oncology tests and tumor profiling
    • Listing is a guide; complete procedure code list available on the Medical Policy Portal

    Genetic and specialty diagnostic tests requiring precertification

    Lists of genetic and specialty tests that are subject to the policy and precertification requirements.

    Genetic test categories requiring precertification

    • Expanded carrier screening panels (examples: Carrier Status DNA Insight, Counsyl Family Prep Screen, Pan-Ethnic Carrier Screening)
    • Hearing loss panels
    • Intellectual disability panels
    • Noonan spectrum disorders panels

    Specialty oncology tests

    • Cancer gene expression or protein signature tests (examples: OncotypeDX, MammaPrint, Afirma, Prosigna, HeproDX)

    Specialty drugs and biologics requiring precertification (commercial plans)

    Specialty drugs and biologics that require precertification for commercial members.

    All listed specialty drugs and their generic equivalents or biosimilars require precertification for members enrolled in commercial plans; the list is subject to change.

    Antineoplastic agents (examples)

    • Abraxane, Adcetris, Adstiladrin, Alymsys (except ophthalmological conditions), Anktiva, Avastin (except ophthalmological conditions), Avzivi, Azedra, Blincyto, Columvi, Cyramza, Darzalex, Darzalex Faspro, Enhertu, Erbitux, Herceptin and many others

    Anti PD-1/PD-L1 monoclonal antibodies

    • Examples include Bavencio, balstilimab, camrelizumab, Imfinzi, Jemperli, Keytruda (including SQ), Libtayo, Loqtorzi, Opdivo (and Opdivo Qvantig), Tecentriq (and Hybreza), and others

    Bone-modifying agents

    Agent inventory (partial)

    Agent lists by category (partial inventory). These lists enumerate agents subject to precertification; no eligibility or utilization criteria are provided in this section.

    Multiple sclerosis agents**

    • Briumvi
    • Lemtrada
    • Ocrevus
    • Tyruko
    • Tysabri

    Myasthenia gravis agents**

    Coding and Billing Codes Requiring Review

    Precertification Process, External Review Vendors, and Drug-class Rules

    Prior Authorization

    Precertification requirement and limitation

    Precertification is required for the listed elective/non-emergency services; precertification does not guarantee coverage and the member's benefit plan terms and exclusions determine coverage.

    Note

    External review vendor — Carelon/AIM

    Precertification review for certain services (for example, day rehabilitation programs and elective ambulance transportation) is performed by Carelon Medical Benefits Management (formerly AIM Specialty Health). The benefit for these Carelon-performed reviews varies based on the member's employer group decision.

    • Carelon performs precertification reviews for specified services.
    • Precertification review benefit varies by employer group.

    Key Definitions and Notes

    Precertification — definition and scope
    DefinitionPrecertification required for elective, non-emergency services; precertification does not guarantee coverage — the member's benefit plan determines coverage and exclusions.
    ScopeApplies to services performed on an elective, non-emergency basis and noted in the precertification list (Medical Policy Portal).
    Action requiredProviders must obtain precertification prior to elective services; review the member's benefit plan for coverage determination.
    Independent review vendors
    Carelon (AIM)Performs precertification reviews for services such as day rehabilitation and elective ambulance transport; benefit for review varies by employer group.
    eviCore (CareCore National, LLC d/b/a eviCore healthcare)
    Policy Summary
    PayerAmeriHealth
    PolicyPrecertification Requirements for Elective (Non‑Emergency) Services
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2025
    Next Review DateN/A
    Key ActionObtain precertification for listed elective/non-emergency services before scheduling; precertification does not guarantee benefit coverage.
    SourceLink
    On This Page
    Precertification-required Services and Test/Agent ListsCoding and Billing Codes Requiring ReviewPrecertification Process, External Review Vendors, and Drug-class RulesKey Definitions and Notes
  1. Tumor molecular profiling (examples: FoundationOne, neoTYPE, OncoPlexDx and others)
  2. Tissue of origin testing (for cancer of unknown primary)
  3. PCA3 testing for prostate cancer
  4. Pharmacogenomic tests

    • Cytochrome P450 metabolism gene testing (CYP2D6, CYP2C9, CYP2C19)
    • Specialized drug response gene panels (examples: Assurex GeneSight, GeneTrait, Genecept, Millennium PGT)
    • Warfarin response testing
    • MGMT methylation analysis for glioblastoma

    Other specialty tests

    • Coronary artery disease risk testing (examples: CorusCAD, CardioIQ, APOE, ACE, KIF6)
    • Heart disease risk testing (examples: CorusCAD, CardioIQ, APOE, ACE, KIF6, MTHFR)

    Genome-wide tests

    • Microarray studies
    • Whole exome testing
    • Whole genome testing
    • Mitochondrial genome or nuclear testing
    Any genetic test billed with non-specific CPT codes 81400-81408 or with unlisted codes 81479, 81599, 84999 requires precertification; precertification review is provided by CareCore National, LLC d/b/a eviCore healthcare and benefit for this review may vary by employer group.
    Examples include Bomyntra, Connexence, Evenity, Jubbonti, Osenvelt, Ospomyv, Prolia, Stoboclo, Wyost, Xgeva, Xbryk

    CAR-T therapies

    • Examples include Abecma, Aucatzyl, Breyanzi, Carvykti, Kymriah, Tecartus, Yescarta

    Enzyme replacement agents

    • Examples include Adzynma, Aldurazyme, Brineura, Cerezyme, Elaprase, Elelyso, Fabrazyme, Kanuma, Lumizyme, Mepsevii, Naglazyme, Nexviazyme, VPRIV, Xenpozyme and others

    Gene replacement / gene editing therapies

    • Examples include Casgevy, Elevidys, Hemgenix, Lenmeldy, Luxturna, Lyfgenia, Roctavian, Skysona, Vyjuvek, Zolgensma, Zynteglo and other listed products

    Immunological agents and IVIG/SCIG

    • Selected IV/SC immunological agents are listed (examples include Actemra IV, Avsola, Cosentyx IV, Benlysta IV, Entyvio IV, Inflectra, Remicade and others)

    Multiple sclerosis and myasthenia gravis agents

    • Multiple sclerosis examples include Briumvi, Lemtrada, Ocrevus, Tyruko, Tysabri; Myasthenia gravis examples include nipocalimab, Vyvgart, Rystiggo, Vyvgart Hytrulo

    Hyaluronate acid products

    • Examples include Cingal, Durolane, Euflexxa, Gel-One, Gelsyn-3, Hyalgan, GenVisc 850, Hymovis, Supartz, Synojoynt, Triluron, TriVisc, VISCO-3

    Classes annotated with ** require precertification for any drug that can be classified under that header, including unlisted brand/generic names and newly FDA-approved drugs/biosimilars during the benefit year.

    nipocalimab
  5. Vyvgart
  6. Rystiggo
  7. Vyvgart Hytrulo
  8. Neutropenia agents

    • Fulphila
    • Fylnetra
    • Granix
    • Grastofil
    • Lapelga
    • Neupogen
    • Nypozi
    • Releuko
    • Rolvedon
    • Stimufend
    • Ryzneuta
    • Udenyca and Udenyca OnBody
    • Ziextenzo

    Ophthalmic agents

    • Ahzantive
    • Beovu
    • bevacizumab-vikg
    • Byooviz
    • Cimerli
    • Enzeevu
    • Eylea (including Eylea HD)
    • Lucentis
    • Susvimo
    • Tepezza
    • Vabysmo

    Pulmonary arterial hypertension agents**

    • Flolan
    • Remodulin
    • Tyvaso
    • Revatio
    • Uptravi IV
    • Ventavis
    • Veletri

    Respiratory agents

    • Cinqair
    • Omlyclo
    • Synagis
    • Xolair

    Respiratory enzymes (alpha-1 antitrypsin)**

    • Aralast
    • Glassia
    • Prolastin
    • Zemaira

    TIL and T-cell therapies**

    • Amtagvi
    • Imdelltra
    • linvoseltamab
    • Tecelra

    Miscellaneous therapeutic agents

    • Adakveo
    • Amvuttra
    • Crysvita
    • Enjaymo
    • Leqvio
    • Onpattro
    • Soliris
    • Spinraza
    • Ultomiris IV
    Note

    External review vendor — eviCore

    Precertification review for proton beam therapy and hyperbaric oxygen therapy is provided by CareCore National, LLC d/b/a eviCore healthcare; the availability of this review and benefit varies based on the member's employer group.

    • eviCore provides precertification review for proton beam and hyperbaric oxygen therapy.
    • Precertification review benefit varies by employer group.
    Note

    External review vendor — Magellan

    Precertification review for applied behavioral analysis (autism spectrum disorder services) is provided by Magellan Healthcare, Inc., an independent company.

    • Magellan performs precertification reviews for applied behavioral analysis.
    • Coverage issued by AmeriHealth entities as noted in the policy.
    Prior Authorization

    Precertification for non-specific/unlisted genetic test codes (81400-81408, 81479, 81599, 84999)

    Any genetic test billed with non-specific CPT codes 81400–81408 or with unlisted codes 81479, 81599, or 84999 requires precertification review; precertification review is provided by CareCore National, LLC d/b/a eviCore healthcare and the review benefit may vary by the member's employer group.

    • CPT codes 81400-81408 flagged for precertification.
    • Unlisted codes that require precertification: 81479, 81599, 84999.
    • eviCore performs the precertification review; benefit varies by employer group.
    Prior Authorization

    Specialty drug precertification requirement

    All specialty drugs listed (and their generic equivalents or biosimilars) require precertification for members enrolled in commercial plans; the specialty drug list is subject to change and Medicare Advantage requirements are published separately.

    • All listed brands and their generic equivalents or biosimilars require precertification for commercial plan members.
    • List is subject to change; Medicare Advantage precertification information is on the Medicare Advantage website.
    Prior Authorization

    Multiple sclerosis agents — precertification required

    Multiple sclerosis agents (classified with **) require precertification. Examples listed include Briumvi, Lemtrada, Ocrevus, Tyruko, and Tysabri.

    • Briumvi
    • Lemtrada
    • Ocrevus
    • Tyruko
    • Tysabri
    Prior Authorization

    Myasthenia gravis agents — precertification required

    Myasthenia gravis agents (classified with **) require precertification. Examples listed include nipocalimab, Vyvgart, Rystiggo, and Vyvgart Hytrulo.

    • nipocalimab
    • Vyvgart
    • Rystiggo
    • Vyvgart Hytrulo
    Prior Authorization

    Neutropenia agents — precertification required

    Neutropenia agents require precertification; listed products include Fulphila, Fylnetra, Granix, Grastofil, Lapelga, Neupogen, Nypozi, Releuko, Rolvedon, Stimufend, Ryzneuta, Udenyca (including OnBody), and Ziextenzo.

    • Fulphila
    • Fylnetra
    • Granix
    • Grastofil
    • Lapelga
    • Neupogen
    • Nypozi
    • Releuko
    • Rolvedon
    • Stimufend
    • Ryzneuta
    • Udenyca (including OnBody)
    • Ziextenzo
    Prior Authorization

    Ophthalmic agents — precertification required

    Ophthalmic agents listed require precertification; examples include Ahzantive, Beovu, bevacizumab-vikg (and other biosimilars), Byooviz, Cimerli, Eylea (including Eylea HD), Lucentis, Susvimo, Vabysmo, and others.

    • Ahzantive
    • Beovu
    • bevacizumab-vikg (biosimilar)
    • Byooviz
    • Cimerli
    • Eylea (including HD)
    • Lucentis
    • Susvimo
    • Vabysmo
    Prior Authorization

    Pulmonary arterial hypertension agents — precertification required

    Pulmonary arterial hypertension agents (classified with **) require precertification. Listed examples include Flolan, Remodulin, Tyvaso, Revatio, Uptravi IV, Ventavis, and Veletri.

    • Flolan
    • Remodulin
    • Tyvaso
    • Revatio
    • Uptravi IV
    • Ventavis
    • Veletri
    Prior Authorization

    Respiratory agents — precertification required

    Respiratory agents listed require precertification; examples include Cinqair, Omlyclo, Synagis, and Xolair.

    • Cinqair
    • Omlyclo
    • Synagis
    • Xolair
    Prior Authorization

    Respiratory enzymes (alpha-1 antitrypsin) — precertification required

    Respiratory enzyme (alpha-1 antitrypsin) products (classified with **) require precertification. Listed products include Aralast, Glassia, Prolastin, and Zemaira.

    • Aralast
    • Glassia
    • Prolastin
    • Zemaira
    Prior Authorization

    TIL and T‑cell therapies — precertification required

    Tumor-infiltrating lymphocyte (TIL) and T‑cell therapies require precertification. Examples listed include Amtagvi, Imdelltra, linvoseltamab, and Tecelra.

    • Amtagvi
    • Imdelltra
    • linvoseltamab
    • Tecelra
    Prior Authorization

    Miscellaneous therapeutic agents — precertification required

    Miscellaneous therapeutic agents listed require precertification; examples include Adakveo, Amvuttra, Crysvita, Enjaymo, Leqvio, Onpattro, Soliris, Spinraza, Ultomiris IV, and many others.

    • Adakveo
    • Amvuttra
    • Crysvita
    • Enjaymo
    • Leqvio
    • Onpattro
    • Soliris
    • Spinraza
    • Ultomiris IV
    Provides precertification review for services including hyperbaric oxygen and proton beam therapy; benefit for review varies by employer group.
    Magellan Healthcare, Inc.Performs precertification review for applied behavioral analysis (autism services).
    eviCore — precertification review provider
    Provider of precertification reviewPrecertification review is provided by CareCore National, LLC d/b/a eviCore healthcare (eviCore), an independent company.
    Benefit variationPrecertification review benefit varies based on the decision by the member's employer group.
    Applicable serviceseviCore performs review for items noted in the policy (see hyaluronate products note) and other services listed where indicated.
    "**" classification note (precertification for entire drug class)
    Meaning of **Drug classes annotated with ** require precertification for any drug that can be classified under that header, including unlisted brand/generic names and new FDA approvals in that class during the benefit year.
    Includes biosimilars and new approvalsThis requirement explicitly includes unlisted brand or generic names and FDA‑approved drugs or biosimilars added during the benefit year.
    Applicability noteApplies to all drug class headers marked with ** in the agent inventory and specialty drug lists within the policy.
    Multiple sclerosis agents (examples)
    CategoryMultiple sclerosis agents
    ExamplesBriumvi, Lemtrada, Ocrevus, Tyruko, Tysabri.
    Precertification ruleThese agents are listed in the policy inventory and require precertification as indicated by the policy's specialty drug precertification requirement.
    Myasthenia gravis agents (examples)
    CategoryMyasthenia gravis agents
    Examplesnipocalimab, Vyvgart, Rystiggo, Vyvgart Hytrulo.
    Precertification ruleThese agents are listed in the policy inventory and require precertification as indicated by the policy's specialty drug precertification requirement.
    Neutropenia agents (examples)
    CategoryNeutropenia agents
    ExamplesFulphila, Fylnetra, Granix, Grastofil, Lapelga, Neupogen, Nypozi, Releuko, Rolvedon, Stimufend, Ryzneuta, Udenyca, Udenyca OnBody, Ziextenzo.
    Precertification ruleThese agents are listed in the policy inventory and require precertification as indicated by the policy's specialty drug precertification requirement.